References

¹Bates, D.W., et al. Effect of computerized physician order entry and a team intervention on prevention of serious medication errors. Journal of the American Medical Association 280(15):1311–1316, 1998.

²Institute of Medicine (IOM). Preventing Medication Errors: Quality Chasm Series. 2007. More information available at http://books.nap.edu/catalog/11623.html; accessed October 31, 2006.

³Markle Foundation. Connecting for Health. More information available at www.connectingforhealth.org; accessed October 31, 2006.

⁴U.S. Food and Drug Administration (FDA) MedWatch. More information available at www.fda.gov/ medwatch; accessed October 31, 2006.

⁵American Medical Association. Ask Me 3. More information available at www.askme3.org; accessed October 31, 2006.

⁶National Council on Patient Information and Education. Talk About Prescriptions. More information available at www.talkaboutrx.org; accessed October 31, 2006.

⁷FDA Workshop. "Streamlining the Blood Donor History Questionnaire." October 2000. More information available at www.fda.gov/cber/minutes/bldqstn101600.htm; accessed October 31, 2006.

⁸FDA Workshop. "Recruiting Blood Donors: Successful Practices." July 2000. More information available at www.fda.gov/ohrms/dockets/ac/00/backgrd/3649b2a.doc; accessed October 31, 2006.

⁹FDA Workshop. "Behavior-Based Donor Deferrals in the NAT Era." March 8, 2006. More information available at www.fda.gov/cber/minutes/nat030806t.htm; accessed October 31, 2006.

¹⁰Steering Committee for the Collaborative Development of a Long-Range Action Plan for the Provision of Useful Prescription Medicine Information. More information available at www.fda.gov/cder/offices/ods/keystone.pdf; accessed October 31, 2006.

¹¹FDA. Guidance: Useful Written Consumer Medication Information (CMI). July 2006. More information available at www.fda.gov/cder/guidance/7139fnl.htm; accessed October 31, 2006.

¹²Thomson, R.A., et al. Retention of safe blood donors. Transfusion 38:359–367, 1998.

¹³Glynn, S.A., et al. Motivations to donate blood: Demographic comparisons. Transfusion 42(2):216–225, 2002.

¹⁴Executive Order: Incentives for the Use of Health Information Technology and Establishing the Position of the National Health Information Technology Coordinator. More information available at www.whitehouse.gov/news/releases/2004/04/20040427-4.html; accessed October 31, 2006.

¹⁵Agency for Healthcare Research and Quality. More information available at www.ahrq.gov/QUAL/rxtherapies/rxria.htm; accessed October 31, 2006.

¹⁶IOM. To Err Is Human: Building a Safer Health System. 2000. More information available at http://books.nap.edu/catalog/9728.html; accessed October 31, 2006.

¹⁷IOM. Crossing the Quality Chasm: A New Health System for the 21st Century. 2001. More information available at http://books.nap.edu/catalog/10027.html; accessed October 31, 2006.

¹⁸FDA. Guidance for Industry: Revised Preventive Measures to Reduce the Possible Risk of Transmission of Creutzfeldt-Jakob Disease (CJD) and Variant Creutzfeldt-Jakob Disease (vCJD) by Blood and Blood Products. More information available at www.fda.gov/cber/gdlns/cjdvcjd.htm; accessed October 31, 2006.

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®.

<<  Previous—Objectives and Subobjectives   |   Table of Contents  |  Next—Related Objectives From Other Focus Areas  >>